Abstract:BackgroundThe molecular mechanisms underlying dysregulation of microRNAs have been documented in nasopharyngeal carcinoma (NPC). Our previous study demonstrated that plasma miR-124 was down-regulated in NPC using microarray analysis and quantitative PCR validation. Though growing studies showed that down-regulated miR-124 was closely related to tumourigenesis in various types of cancers, the role of miR-124 in NPC remains largely unknown.MethodsThe expression level of miR-124 was evaluated in NPC cell lines and patient specimens using quantitative reverse transcription-PCR (Real-time qPCR). The clinicopathological significance of the resultant data was later analyzed. Then, we explored the role of miR-124 in NPC tumorigenesis by in vitro and in vivo experiments. Homo sapiens forkhead box Q1 (Foxq1) was confirmed as a novel direct target gene of miR-124 by the dual-luciferase assay and western bolt.ResultsWe found that miR-124 was commonly down-regulated in NPC specimens and NPC cell lines. The expression of miR-124 was inversely correlation with clinical stages and marked on T stages. Then, the ectopic expression of miR-124 dramatically inhibited cell proliferation, colony formation, migration and invasion in vitro, as well as tumor growth and metastasis in vivo. Furthermore, we identified Foxq1 as a novel direct target of miR-124. Functional studies showed that knockdown of Foxq1 inhibited cell growth, migration and invasion, whereas Foxq1 overexpression partially rescued the suppressive effect of miR-124 in NPC. In clinical specimens, Foxq1 was commonly up-regulated in NPC, and the level increased with clinical stages and T stages. Additionally, the level of Foxq1 was inversely correlated with miR-124.ConclusionsOur results demonstrate that miR-124 functions as a tumor-suppressive microRNA in NPC, and that its suppressive effects are mediated chiefly by repressing Foxq1 expression. MiR-124 could serve as an independent biomarker to identify patients with different clinical characteristics. Therefore, our findings provide valuable clues toward the understanding the of mechanisms of NPC pathogenesis and provide an opportunity to develop new effective clinical therapies in the future.

LncRNA FOXP4-AS1 Silencing Inhibits Metastasis and Epithelial–mesenchymal Transition in Nasopharyngeal Carcinoma Via Mir-136-5p/mapk1

LncRNA HOXC-AS1 Promotes Nasopharyngeal Carcinoma (NPC) Progression by Sponging Mir-4651 and Subsequently Upregulating FOXO6.

LncRNA EPB41L4A-AS2 Represses Nasopharyngeal Carcinoma Metastasis by Binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm

Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma

LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting As Cerna to Sponge Mir-520A-3p and Upregulate MAPK1 Expression

miRNA‐22‐3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1

miR-137 Inhibition of the Invasion, Metastasis, and Epithelial-Mesenchymal Transition of Nasopharyngeal Cancer by Regulating KDM1A

Long Non-Coding RNA GNAS-AS1 Promotes Cell Migration and Invasion Via Regulating Wnt/β-catenin Pathway in Nasopharyngeal Carcinoma.

EZH2-DNMT1-mediated Epigenetic Silencing of Mir-142-3p Promotes Metastasis Through Targeting ZEB2 in Nasopharyngeal Carcinoma

Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma Via Microrna-195-dependent Inhibition of SMAD5.

Long Noncoding RNA ZFAS1 Promotes Tumorigenesis and Metastasis in Nasopharyngeal Carcinoma by Sponging Mir‐892b to Up‐regulate LPAR1 Expression

Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis

Mir-145 Inhibits Metastasis By Targeting Fascin Actin-Bundling Protein 1 In Nasopharyngeal Carcinoma

LncRNA FOXD3-AS1 Promotes the Malignant Progression of Nasopharyngeal Carcinoma Through Enhancing the Transcription of YBX1 by H3K27Ac Modification

MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma

The M6a Methyltransferase METTL3 Affects Autophagy and Progression of Nasopharyngeal Carcinoma by Regulating the Stability of Lncrna ZFAS1

MicroRNA-30a Promotes Invasiveness and Metastasis in Vitro and in Vivo Through Epithelial-Mesenchymal Transition and Results in Poor Survival of Nasopharyngeal Carcinoma Patients.

The Long Non-Coding RNA MACC1-AS1 Promotes Nasopharyngeal Carcinoma Cell Stemness Via Suppressing Mir-145-mediated Inhibition on SMAD2/MACC1-AS1 Axis

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma

LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes

FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells Through Repressing Mir-100-5p and Mir-125B-5p.